semaglutide injection med spa GLP-1 Semaglutide | Stunning Med Spa

Acute Gallbladder Disease Treatment with WEGOVY is associated with an increased occurrence of cholelithiasis and cholecystitis

The drugs have been shown in studies to reduce the risk of heart and kidney disease and lower average blood sugar levels in people with type 1 diabetes

A study published in 2024 looked at people switching from a GLP-1 receptor agonist to tirzepatide 5mg

You may be prescribed Wegovy if you: Have a BMI of 30 or more, or Have a BMI of 27 or more with a weight-related health condition You may be prescribed Ozempic if you: Have type 2 diabetes and need help with blood sugar control Meet the weight criteria and are using it off-label for weight loss under clinical guidance Neither medication is suitable for pregnant or breastfeeding patients